Avalo Therapeutics (AVTX) Return on Invested Capital (2017 - 2020)
Avalo Therapeutics (AVTX) posted Return on Invested Capital of 0.24% for Q2 2020, down 136.02% on a QoQ basis from 0.1% in Q1 2020, and down 19.0% year-over-year from 0.3% in Q3 2019.
Avalo Therapeutics (AVTX) Return on Invested Capital (2017 - 2020) Analysis & Trends
Avalo Therapeutics' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.24% for Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -0.24% |
| Mar 31, 2020 | -0.10% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.05% |
| Mar 31, 2019 | -0.07% |
| Dec 31, 2018 | -0.08% |
| Sep 30, 2018 | -0.13% |
| Jun 30, 2018 | 0.04% |
| Mar 31, 2018 | 0.06% |
| Dec 31, 2017 | 0.04% |
| Sep 30, 2017 | 0.02% |